This full day Industry Masterclass in Drug Discovery and Development convenes industry executives from across drug discovery and development disciplines to highlight strategic considerations on the new drug journey from target to clinic. Co-organised by Professor Fiona Ducotterd, Alzheimer’s Research UK UCL Drug Discovery Institute, and Doctor Jim Ray, Belfer Neurodegeneration Consortium, MD Anderson Neuroscience Drug Discovery Institute, this program will provide strategic insights into the long and interdisciplinary process that moves discoveries towards patients and the translation of academic innovations into new treatments.

The day will also feature a panel session on what makes projects investible with stakeholders from VC, biotech and pharma and an R&D leader roundtable on the current and future landscape for neurodegenerative diseases and a keynote speaker will share a personal journey from academic discovery to scientific founder.

The program will provide strategic understanding of the new drug journey across functions and celebrate the interdisciplinary expertise that bring together bench to bedside translation of neurology research into new treatments.

For event information of vendor opportunities please contact Professor Fiona Ducotterd, f.ducotterd@ucl.ac.uk